Red List

CELCCelcuity Inc.

Healthcare · Biotechnology · mid-cap ($4.3B)
-40.0%
from rolling 252-day high of $151.02 set 2026-05-04 · 108d ago
Current
$90.57
Decline depth
-40.0%
Decline σ
1.7σ
TFC
2/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$CELC landed on the list 2026-06-02, down 39.5% from its 52-week high that day — now down -40.0%.

It has clawed back 1.4 percentage points off that level. It bottomed 45.5% below that high along the way.

Decline from the 52-week high as it stood on 2026-06-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

CELC qualifies for the Red List on decline depth.

Decline depth
-40.0%
From rolling 252-day high of $151.02, 108d ago. Past the 40% Red List threshold.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
1.7σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (3.44% per day).

The structural read

What price action says about CELC.

CELC qualifies for the Red List on decline depth — down -40.0% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy. Depth plus recency: this is the pattern many investors call a falling knife.

Earnings on file: 2026-05-14. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about CELC

What people ask.

Why is CELC on Broken Stocks?

CELC qualifies for the Red List on decline depth. It is down -40.0% from its rolling 252-day high of $151.02, set on 2026-05-04 — 108d ago.

Is CELC a falling knife?

By the most common technical definition — a steep, recent breakdown from a fresh high — yes. CELC is down -40.0% from its 52-week high of $151.02, set 108d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.

Is CELC a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is CELC trading inside its 52-week range?

At $90.57, CELC sits 56.0% of the way from its 52-week low ($13.59) to its 52-week high ($151.02). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has CELC been declining?

The current 40.0% decline accrued over 108d, which annualizes to roughly -135.2% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does CELC compare to its sector?

There are 143 other Healthcare tickers on Broken Stocks: 69 Red, 35 Amber, 39 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — CELC's decline is deeper than the sector median.

Does CELC's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-14) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.